Grifols Sa Adr Stock Operating Margin
GIKLY Stock | USD 4.52 0.05 1.12% |
Grifols SA ADR fundamentals help investors to digest information that contributes to Grifols SA's financial success or failures. It also enables traders to predict the movement of Grifols Pink Sheet. The fundamental analysis module provides a way to measure Grifols SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Grifols SA pink sheet.
Grifols |
Grifols Operating Margin Analysis
Grifols SA's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Grifols SA Operating Margin | 0.09 % |
Most of Grifols SA's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grifols SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Grifols SA ADR has an Operating Margin of 0.0887%. This is 100.25% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 101.61% lower than that of the firm.
Grifols Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Grifols SA's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Grifols SA could also be used in its relative valuation, which is a method of valuing Grifols SA by comparing valuation metrics of similar companies.Grifols SA is currently under evaluation in operating margin category among related companies.
Grifols Fundamentals
Return On Equity | 0.0182 | |||
Return On Asset | 0.0155 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 16.07 B | |||
Shares Outstanding | 1.36 B | |||
Shares Owned By Institutions | 0.02 % | |||
Price To Earning | 9.31 X | |||
Price To Book | 1.03 X | |||
Price To Sales | 1.47 X | |||
Revenue | 4.93 B | |||
Gross Profit | 1.96 B | |||
EBITDA | 861.51 M | |||
Net Income | 182.8 M | |||
Cash And Equivalents | 549.09 M | |||
Cash Per Share | 0.40 X | |||
Total Debt | 6.1 B | |||
Debt To Equity | 1.14 % | |||
Current Ratio | 2.68 X | |||
Book Value Per Share | 4.66 X | |||
Cash Flow From Operations | 596.98 M | |||
Earnings Per Share | 0.05 X | |||
Price To Earnings To Growth | 0.53 X | |||
Target Price | 55.5 | |||
Number Of Employees | 27.58 K | |||
Beta | 0.48 | |||
Market Capitalization | 9.97 B | |||
Total Asset | 19.23 B | |||
Retained Earnings | 468 M | |||
Working Capital | 2.03 B | |||
Current Asset | 2.95 B | |||
Current Liabilities | 926 M | |||
Z Score | 0.6 | |||
Annual Yield | 0.03 % | |||
Five Year Return | 1.50 % | |||
Net Asset | 19.23 B |
About Grifols SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Grifols SA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grifols SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grifols SA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 27584 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Grifols SA Piotroski F Score and Grifols SA Altman Z Score analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Grifols Pink Sheet analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |